IPF is most effective when the measurement is used serially and interpreted in conjunction with the
platelet count.
Third,
platelet counts increased gradually within 48 h of discontinuation of UFH and Low molecular weight heparin and returned to 88 x 10 [sup]9 /L within 5 days.
Not all fever is dengue and low
platelet count is not only because of dengue fever There are several diseases that have similar symptoms,fever and low
platelet count,such as chikungunya,yellow fever,HIV,hepatitis B and C,protozoan parasite infection like malaria,or bacterial infections like leptospirosis The message government wants to disseminate among the public is not going in the right way.
This study aims to determine the relative frequency of different disease conditions presenting as newly found throm-bocytopenia in adult patients, to determine the proportions of patients who had bleeding manifestations and the different bleeding manifestations in order of their commonness of occurring, and to determine whether a low
platelet count or presence of bleeding manifestation was considered more often as indicator for platelet transfusion.
In their study mean
platelet count in HCV positive was 180A-109/l which was close to mean plate-let count of 198.
After incubation, the
platelet counts in the tubes were determined, and the results compared to the original
platelet count of the NPRP.
Key Words:
Platelet count, Platecrit (PCT), Mean platelet volume (MPV), Platelet distribution width (PDW), Total cholesterol, Triglycerides.
Warfarin should be avoided until
platelet counts have recovered to normal levels.
previously disclosed that
platelet counts were increased after intravenous PEG-reHuMGDF, a truncated recombinant version of c-mpl ligand (thrombopoietin), in aplastic anemia and myelodysplasia.
11] The present case had 3 risk factors: a genital tumour, high
platelet count (532 x 10[sup.
Platelet count was done by fully automated counter and the results were derived from directly measured platelet pulses, multiplied by a calibration constant and expressed in 1000 thrombocytes/[micro]l of whole blood.
The following parameters were collected: age, gender, hematocrit before and after line placement, lactic dehydrogenase (LDH), peripheral smear findings and
platelet count on presentation, ADAMTS-13 activity and inhibitor, estimated blood loss during line placement, presence or absence of platelet transfusions prior to line placement and the clinical service placing the line.
